Van Herle A J, Demeester-Mirkine N, Van Heuverswyn B, Dumont J
J Endocrinol Invest. 1981 Jan-Mar;4(1):107-20. doi: 10.1007/BF03349426.
The concentration of serum thyroglobulin was measured in sera of subjects with various thyroid disorders, before and after the administration of tracer doses of 131I. The mean serum human thyroglobulin (hTg) concentration before administration of the isotope was 35.2 ng/ml +/- 7.8 (SE) in 13 subjects and 36.3 ng/ml +/- 7.9 (SE) 24 h after the administration of 131I. The data indicate that no significant release of thyroglobulin occurs 24 h after the administration of tracer doses of 131I. In 2 of the 3 subjects, however, in whom samples were obtained at 4 and 8 h after diagnostic administration of 131I, a modest rise in serum Tg levels was observed. Determinations of serum thyroglobulin levels within 24 h after the administration of a tracer dose of 131I are nevertheless valid providing one allows sufficient time to elapse for tracer decay.
在给予示踪剂量的131I之前和之后,测量了患有各种甲状腺疾病的受试者血清中的甲状腺球蛋白浓度。在13名受试者中,给予同位素前血清人甲状腺球蛋白(hTg)的平均浓度为35.2 ng/ml±7.8(标准误),给予131I后24小时为36.3 ng/ml±7.9(标准误)。数据表明,给予示踪剂量的131I后24小时,甲状腺球蛋白没有显著释放。然而,在3名受试者中的2名,在诊断性给予131I后4小时和8小时采集样本,观察到血清Tg水平有适度升高。尽管如此,在给予示踪剂量的131I后24小时内测定血清甲状腺球蛋白水平仍然有效,前提是给予足够的时间让示踪剂衰变。